Therapeutics
IgG Protease
Enzymes that modulate immune response.
Evozyne solves high-impact problems in human health.
Our products are high-performance, adaptive proteins with exceptionally advanced functionality.
We are pursuing life-changing treatments for patients and finding ways to potentially cure untreatable diseases.
NVIDIA Partnership Highlight
Evozyne collaborated with NVIDIA to create and validate a new AI model that the pharmaceutical industry can use to design therapeutic proteins.
The novel approach exponentially increased the number and quality of synthetic protein designs for experimental testing. That capability translates to the ability to design new therapeutic targets for currently untreated diseases and greatly reduces development time for new therapies.
Takeda and Evozyne are partnering to utilize innovative protein engineering technology to address treatment challenges in rare diseases, and to develop transformative therapy for patients.